REVB Revelation Bio: Earnings per share for the last twelve months
Revelation Biosciences is developing immunotherapy where formula approvals will provide massive profit leverage with low costs. The net income per share over the last 12 months demonstrates current trends, with -42.60 recorded as the baseline value. Funding relies on institutional capital due to the absence of stable revenue, while patents and strict oversight create a robust defensive barrier.
Analytical breakdowns and data insights for company Revelation Biosciences Corp (REVB)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Revelation Biosciences|REVB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Revelation Biosciences|REVB - Aggregate Debt Obligations|Debts to Book Capitalization Revelation Biosciences, Inc.|REVB - Long-Term Debt|Company Current Liabilities Revelation Biosciences|Quick Ratio revbiosciences.com
- earnings and valuation multiples indicators:
REVB - Company Net Income|Expected Profit Revelation Biosciences|REVB - Price to Earnings Ratio|Forward P/E Multiple Revelation Biosciences Inc|REVB - PEG Multiple|Enterprise Value to EBITDA Ratio Revelation Biosciences, Inc.|REVB - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Revelation Biosciences|REVB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months revbiosciences.com|REVB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Revelation Biosciences
- sales and revenue data:
General company analysis:Revelation Biosciences Corp (REVB)
EPS TTM measures the actual annual earnings per share, neutralizing the impact of security issuances or share buybacks. This indicator allows for an assessment of the business's financial viability regardless of market noise. By analyzing the trend of fundamental TTM earnings per share, an investor can see the monetization rates of Revelation Biosciences (REVB) patents. For a biotech company, this trend is critical until the completion of clinical trials and FDA approval. Growth in this metric confirms capital resilience against the debt load.
Main competitors
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Grifols - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (adaptivebiotech.com)|Celldex (CLDX) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Earnings per share for the last twelve months Pharming Group NV PHAR|Net earnings per share (EPS TTM) Nektar Therapeutics Inc NKTR|Upstream Bio, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ZBIO (Zenas Biopharma, Inc.)|immunome.com (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months gossamerbio.com (GOSS)|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Shattuck Labs - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) equilliumbio.com EQ|connectbiopharm.com - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
